CPT1A mediates radiation sensitivity in colorectal cancer
eLife · 28.11.2024 · 13
DOI: 10.7554/elife.97827 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 28.11.2024. Verfasst von Zhenhui Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, G…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Radiation Tolerance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Science and Technology Brainstorm Project of Guangzhou.
Abstract (Originalsprache)
The prevalence and mortality rates of colorectal cancer (CRC) are increasing worldwide. Radiation resistance hinders radiotherapy, a standard treatment for advanced CRC, leading to local recurrence and metastasis. Elucidating the molecular mechanisms underlying radioresistance in CRC is critical to enhance therapeutic efficacy and patient outcomes. Bioinformatic analysis and tumour tissue examination were conducted to investigate the CPT1A mRNA and protein levels in CRC and their correlation with radiotherapy efficacy. Furthermore, lentiviral overexpression and CRISPR/Cas9 lentiviral vectors, along with in vitro and in vivo radiation experiments, were used to explore the effect of CPT1A on radiosensitivity. Additionally, transcriptomic sequencing, molecular biology experiments, and bioinformatic analyses were employed to elucidate the molecular mechanisms by which CPT1A regulates radiosensitivity. CPT1A was significantly downregulated in CRC and negatively correlated with responsiveness to neoadjuvant radiotherapy. Functional studies suggested that CPT1A mediates radiosensitivity, influencing reactive oxygen species (ROS) scavenging and DNA damage response. Transcriptomic and molecular analyses highlighted the involvement of the peroxisomal pathway. Mechanistic exploration revealed that CPT1A downregulates the FOXM1-SOD1/SOD2/CAT axis, moderating cellular ROS levels after irradiation and enhancing radiosensitivity. CPT1A downregulation contributes to radioresistance in CRC by augmenting the FOXM1-mediated antioxidant response. Thus, CPT1A is a potential biomarker of radiosensitivity and a novel target for overcoming radioresistance, offering a future direction to enhance CRC radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial…
- Department of Pathology, Nanfang Hospital and School of Basic Medical Science, Southern Medical University, Guangzhou, China.
- HuiQiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Förderung
- National Natural Science Foundation of China
- Key Science and Technology Brainstorm Project of Guangzhou
Zitieren
APA
Chen, Z., Yu, L., Zheng, Z., Wang, X., Guo, Q., Chen, Y., Zhang, Y., Zhang, Y., Xiao, J., Chen, K., Fan, H., & Ding, Y. (2024). CPT1A mediates radiation sensitivity in colorectal cancer. eLife, 13. https://doi.org/10.7554/elife.97827
Vancouver
Chen Z, Yu L, Zheng Z, Wang X, Guo Q, Chen Y, et al. CPT1A mediates radiation sensitivity in colorectal cancer. eLife. 2024;13. doi:10.7554/elife.97827
BibTeX
@article{Chen2024,
author = {Chen, Zhenhui and Yu, Lu and Zheng, Zhihao and Wang, Xusheng and Guo, Qiqing and Chen, Yuchuan and Zhang, Yaowei and Zhang, Yuqin and Xiao, Jianbiao and Chen, Keli and Fan, Hongying and Ding, Yi},
title = {CPT1A mediates radiation sensitivity in colorectal cancer},
journal = {eLife},
year = {2024},
volume = {13},
doi = {10.7554/elife.97827}
}
EUVIMED